Ikena Oncology, Inc.IKNANASDAQ
Loading
Year-over-year research & development expense growth
Percentile
P43
Within normal range
vs 5Y Ago
-0.1x
Contraction
Streak
1 yr
Consecutive growthRecovering
| Period | Value |
|---|---|
| 2025 | -6.12% |
| 2024 | -49.06% |
| 2023 | -7.26% |
| 2022 | 36.54% |
| 2021 | 5.04% |
| 2020 | 79.83% |
| 2019 | -35.33% |
| 2018 | 0.00% |